196300 Stock Chart & Stats
₩3915.00
₩30.00(0.77%)
―
--
Day’s Range― - ―
52-Week Range₩3,510.00 - ₩9,990.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)27.97K
Market Cap
₩36.71B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.29
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding9,376,439
10 Day Avg. Volume63,377
30 Day Avg. Volume27,973
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
196300 FAQ
What was HLB Pep Co. Ltd.’s price range in the past 12 months?
HLB Pep Co. Ltd. lowest stock price was ₩3510.00 and its highest was ₩9990.00 in the past 12 months.
What is HLB Pep Co. Ltd.’s market cap?
HLB Pep Co. Ltd.’s market cap is ₩36.71B.
When is HLB Pep Co. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HLB Pep Co. Ltd.’s earnings last quarter?
Currently, no data Available
Is HLB Pep Co. Ltd. overvalued?
According to Wall Street analysts HLB Pep Co. Ltd.’s price is currently Undervalued.
Does HLB Pep Co. Ltd. pay dividends?
HLB Pep Co. Ltd. does not currently pay dividends.
What is HLB Pep Co. Ltd.’s EPS estimate?
HLB Pep Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HLB Pep Co. Ltd. have?
HLB Pep Co. Ltd. has 9,376,439 shares outstanding.
What happened to HLB Pep Co. Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HLB Pep Co. Ltd.?
Currently, no hedge funds are holding shares in KR:196300
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Seoulin Bioscience Co.,Ltd.
―
SYNTEKABIO, INC.
―
Gencurix, Inc.
―
KAINOS MEDICINE INC.
―
Oncocross Co., Ltd.
―